Randomised Controlled TrialtcVNSn = 59

Chronic migraine headache prevention with noninvasive vagus nerve stimulation: The EVENT study

Silberstein SD, Calhoun AH, Lipton RB, Grosberg BM, Cady RK, Dorlas S, Simmons KA, Mullin C, Liebler EJ, Goadsby PJ, et al.

Neurology · 2016

Key finding

First sham-controlled pilot study of nVNS for chronic migraine prevention; open-label completers showed approximately 7.9 fewer headache days after 8 months of sustained therapy.

Condition
Migraine
Stimulation
tcVNS
Evidence tier
Randomised Controlled Trial
Participants
59
View on DOI

Cite this study

Silberstein, S. D., Calhoun, A. H., Lipton, R. B., Grosberg, B. M., Cady, R. K., Dorlas, S., Simmons, K. A., Mullin, C., Liebler, E. J., Goadsby, P. J., Saper, J. R., Calhoun, A. H., Cady, R. K., Dexter, J., Silberstein, S. D., Young, W., Marmura, M., Nahas-Geiger, S., Da Silva, A., … Eller, M. (2016). Chronic migraine headache prevention with noninvasive vagus nerve stimulation: The EVENT study. Neurology, 87(5), 529-538. https://doi.org/10.1212/WNL.0000000000002918

Related studies in Migraine

Summary by Vagus Research. Always consult the primary source for the authoritative record.

Stay Current with the Research

Join researchers and practitioners exploring the science of vagus nerve stimulation. Receive curated research summaries and evidence updates.

No spam. Unsubscribe at any time. We respect your privacy.